Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Karolinska Institutet | OTHER |
Not provided
Not provided
Not provided
The aim of the current study, embedded in The Danish FGID Treatment Study, is to test Danish versions of Swedish i-CBT programs for children and adolescents with FGID in a Danish clinical context and to further evaluate the presence and impact of important psychological and parental factors.
Functional gastrointestinal disorders (FGID) are common among children and adolescents. They affect quality of life, cause functional disability, school absence and high health care use.
Parental behavior can significantly influence the young person's perception of bodily symptoms, which are thought to be part of development and maintenance of symptoms FGID. So are cognitive biases which are distortions in attention, memory and interpretation.
The programs involve both the youth and their parents, which provides a unique possibility, to examine illness-related cognitive biases and the effectiveness of graded exposure in youths with FGID with an additional focus on parental distress and illness worries for treatment adherence and outcome.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Children and Adolescents | Experimental | 30 children aged 8-12 years old and their parents, 30 adolescents aged 13-17 years old and their parents |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Internet delivered cognitive behavioural therapy for functional gastrointestinal disorders | Other | The offered treatment will be the Danish versions of the Swedish i-CBT programs for children. The child i-CBT program consists of 10 modules for the child and 10 for parents. The adolescent i-CBT program consists of 10 modules for the adolescent and 5 modules for the parents. Child and adolescents modules compose of exposure exercises for symptoms, behavioural analyses and affect labelling and are adjusted for the specific age group. Parent modules aim at supporting parents in helping their child to engage in the challenging exposure exercises. The family needs to select one parent to participate in the parent program. The participants will be expected to use approximately 4 hours per week. The programs will be delivered over ten weeks, and therapist support will be provided on a weekly basis. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in gastrointestinal symptoms assessed by PedsQL Gastro Symptom Scales | The self-report questionnaire revised version of PedsQL Gastro Symptom Scales, with 9 items. Answered on a 5 point scale from 0 ("never") to 4 ("almost always) | At baseline, after 5 weeks of treatment (mid-treatment), after 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up)] |
| Change in gastrointestinal symptoms rated by parents assessed by PedsQL Gastro Symptom Scales | The parent-report questionnaire revised version of PedsQL Gastro Symptom Scales, with 9 items. Answered on a 5 point scale from 0 ("never") to 4 ("almost always) | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up)] |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in cognitive biases in interpretation and memory of stimuli related to gastrointestinal themes, leisure and school: Picture Task. | Online experimental task with a picture task, with 15 pictures rated on emotional valence (0 negative, 100 positive), physical reaction (1 nota at all, 7 very much) and relatability to own life (1 not at all, 7 very much). Pictures are then recalled and rated on emotional valence (0 negative, 100 positive) and physical reaction (1 nota at all, 7 very much). Lastly pictures are recognised from unfamiliar pictures and rated on difficulty (1 not at all, 7 very much) and confidence (1 not at all, 7 very much). |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment satisfaction by the self-report questionnaire Modified Experience of Service Questionnaire Modified Experience of Service Questionnaire | 10 items rated either true, partly true, not true or don't know and 3 open end questions | At 10 weeks of treatment (End of treatment) |
| Adverse events |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Charlotte Ulrikka Rask, Professor, MD, PhD | Aarhus University and Aarhus University Hospital, Child and Adolescents Psychiatry | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University and Aarhus University Hospital, Child and Adolescents Psychiatry | Aarhus | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42057915 | Derived | Nielsen ES, Kallesoe KH, Frostholm L, Jonsson IM, Johansen KB, Lalouni M, Bonnert M, Rask CU. Internet-delivered cognitive behavioral therapy for pediatric functional abdominal pain disorders: Parental factors in treatment response. Internet Interv. 2026 Apr 20;44:100941. doi: 10.1016/j.invent.2026.100941. eCollection 2026 Jun. | |
| 39773759 |
Not provided
Not provided
Not provided
An open end pilot study including 30 children and 30 adolescents and their parents (n=60)
Not provided
Not provided
Not provided
Not provided
|
| At baseline and 10-weeks of treatment (end of treatment) |
| Changes in cognitive biases in interpretation and memory of stimuli related to gastrointestinal themes, leisure and school: Health Norms sorting Task. | Online experimental task with FGID-specific version of the Health Norms Sorting Task, Participants sort 20 words as healthy or no longer healthy, recall as many words as possible and lastly recognise from previously unfamiliar words while rating on difficulty (1 not at all, 7 very much) and confidence (1 not at all, 7 very much). | At baseline and 10-weeks of treatment (end of treatment) |
| Changes in Quality of life assessed by the Pediatric Quality of Life Inventory | The self-report questionnaire Pediatric Quality of Life Inventory 8-12-year version for children, 13-18-year version for adolescents. 23 items, Answered on a 5 point scale from 0 ("never") to 4 ("almost always) | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Quality of life rated by parents assessed by Pediatric Quality of Life Inventory | The parent-report questionnaire Pediatric Quality of Life Inventory for parents, (Parent report for children aged 8-12 years, and parent report for adolescents aged 13-17 years) . 23 items, Answered on a 5 point scale from 0 ("never") to 4 ("almost always) | Time Frame: At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Pain intensity measured by the self-report rating scale, Faces pain scale, revised | The scale consists of 6 faces representing least to most pain, and each face is connected to a number from 0 (no pain) - 10 (most pain), | At baseline, after 5 weeks of treatment (mid-treatment), after 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Pain intensity rated by parents Measured by the parent-report rating scale, Faces pain scale, revised | The scale consists of 6 faces representing least to most pain, and each face is connected to a number from 0 (no pain) - 10 (most pain), | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up)] |
| Changes in Overall symptom load measured by the self-report questionnaire Children somatization inventory , short (CSI) | The questionnaire consist of 24 items Answered on a 5 point scale from 0 ("not at all") to 4 ("a whole lot") | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Overall symptom load rated by parents measured by the parent-report questionnaire Children somatization inventory (parent report), short | The questionnaire consists of 24 items Answered on a 5 point scale from 0 ("not at all") to 4 ("a whole lot") | At baseline, after 5 weeks of treatment (mid-treatment), after 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Depression symptoms measured by the self-report questionnaire Mood and Feelings Questionnaire short | The questionnaire consists of 13 items, answered on a 3 point scale: not true / sometimes true / true | At baseline, 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in General Anxiety symptoms measured by the self- report questionnaire Spence Children Anxiety Scale short | A 19 item-questionnaire answered on a 4 point scale from 0(never) to 3 (always) | At baseline, 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in General Anxiety rated by parents, Measured by the parent- report questionnaire Spence Children Anxiety Scale short, parent report | A 19 item-questionnaire answered on a 4 point scale from 0(never) to 3 (always) | At baseline, 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up)] |
| Changes in Specific Gastrointestinal Anxiety, Measured by the self-report questionnaire Visceral Sensitivity Index -Short | A 7 item-questionnaire answered on a 5 point scale from 0 (don't agree at all) to 5 (totally agree) | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Avoidance and control behaviour measured by the self-report questionnaire irritable bowel syndrome behavioural response questionnaire | A 11 item-questionnaire answered on a 7 point likert scale from 1(never) to 7(always) | At baseline, after 5 weeks of treatment (mid-treatment), after 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Illness perception Measured by the self-report questionnaire Brief Illness perception Questionnaire | A questionnaire with 11 items answered on a scale from 0 - 10 | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Illness perception rated by parents, measured by the parent-report questionnaire Illness perception regarding child's symptoms Questionnaire | A questionnaire with 11 items answered on a scale from 0 - 10 | At baseline, after 5 weeks of treatment (mid-treatment), after 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Illness worry Measured by the self-report questionnaire Childhood Illness Attitude Scale | The fear-factor domain of the questionnaire is used, it consists of 11 items, answers: never, sometimes or always | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Acceptance, measured by the self-report questionnaire Chronic pain Acceptance Questionnaire -adolescents | Two items from the self-report questionnaire Chronic pain Acceptance Questionnaire -adolescents are used. 2 selected items, answered on a 5-point scale from 0 (never true) to 4 (always true) | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in PARENTAL Illness Worry measured by the self-report The Health Anxiety by Proxy Scale (HAPYS) questionnaire | Parental illness worry for their child, measured by the self-report The questionnaire covers 26 items about health anxiety by proxy, rated on a five-point scale (from "not at all"/"never" to "a whole lot"/"most of the time"). And five items about the impact of the worries rated on a four-point scale (from "no" to "yes, severely"). | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in PARENTAL Emotional distress measured by the self-report questionnaire Symptom Check List (SCL-8) | The questionnaire consists of 8 items answered on a 5 point scale from 0 (not at all) to 4 (a whole lot) | At baseline, after 5 weeks of treatment (mid-treatment), after 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in Adult Response to Child's Symptoms - PARENTS by the self-report questionnaire Adult Response to Children's Symptoms | Protect and Monitor scale from the the questionnaire Adult Response to Children's Symptoms used, 15 items answered on a 5 point scale from 0(never) to 4 (always) | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
| Changes in School absence / Work absence parent | Question about Hours / Days missed from school/work last month. Parental report for children aged 8-12 years, self-report for adolescents aged 13-17 years, self-report for parents | At baseline, 5 weeks of treatment (mid-treatment), 10 weeks of treatment (end-treatment) and 3-months after treatment (follow-up) |
Open end questions. Parents to children aged 8-12 years will answer on behalf of their children and adolescents aged 13-17 years will answer themselves. |
| At 10 weeks of treatment (End of treatment) |
| Skovslund Nielsen E, Kallesoe K, Bennedsen Gehrt T, Bjerre-Nielsen E, Lalouni M, Frostholm L, Bonnert M, Rask CU. Trajectories of Change, Illness Understanding, and Parental Worries in Children and Adolescents Undergoing Internet-Delivered Cognitive-Behavioral Therapy for Functional Abdominal Pain Disorders: Protocol for a Single-Case Design and Explorative Pilot Study. JMIR Res Protoc. 2025 Jan 7;14:e58563. doi: 10.2196/58563. |
| ID | Term |
|---|---|
| D005767 | Gastrointestinal Diseases |
| D043183 | Irritable Bowel Syndrome |
| ID | Term |
|---|---|
| D004066 | Digestive System Diseases |
| D003109 | Colonic Diseases, Functional |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided